Filing Flows › Sanara MedTech (SMTI) › Capital expenditures
Sanara MedTech (SMTI) capital expenditures by quarter
Sanara MedTech's capital expenditures were $5K in Q2 2026 (second quarter 2026), -94% from Q4 2025. Over the last 5 quarters it ranged from $5K (Q2 2026) to $1.8M (Q2 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $5K | -94% | -100% |
| Q4 2025 | $82K | -92% | +14% |
| Q3 2025 | $1.1M | -40% | — |
| Q2 2025 | $1.8M | 24× | — |
| Q4 2024 | $72K | — | — |
Q2 2026 at a glance
Sanara MedTech, Q2 2026: revenue $28.1M (+9% year over year), operating margin 6.3%, net loss $453K, operating cash flow $2.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Sanara MedTech's capital expenditures?
Sanara MedTech's capital expenditures were $5K in Q2 2026 (second quarter 2026), -94% from Q4 2025.
How has Sanara MedTech's capital expenditures changed?
Over the last 5 quarters it ranged from $5K (Q2 2026) to $1.8M (Q2 2025).